Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
39,534,183
-
Share change
-
+3,850,626
-
Total reported value
-
$161,694,147
-
Put/Call ratio
-
91%
-
Price per share
-
$4.09
-
Number of holders
-
81
-
Value change
-
+$13,084,320
-
Number of buys
-
54
-
Number of sells
-
35
Institutional Holders of AUGMEDIX INC - COM (AUGX) as of Q1 2024
As of 31 Mar 2024,
AUGMEDIX INC - COM (AUGX) was held by
81 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,534,183 shares.
The largest 10 holders included
Redmile Group, LLC, Samjo Management, LLC, CITADEL ADVISORS LLC, PERKINS CAPITAL MANAGEMENT INC, VANGUARD GROUP INC, Balyasny Asset Management L.P., Parkman Healthcare Partners LLC, MILLENNIUM MANAGEMENT LLC, Rhenman & Partners Asset Management AB, and Russell Investments Group, Ltd..
This page lists
81
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.